Antimicrobial Resistance ofCampylobacterspp. Causing Human Infection in Australia: An International Comparison
Rhiannon L Wallace, Dieter Bulach, Angus McLure, Liana Varrone, Amy V Jennison, Mary Valcanis, James J Smith, Benjamin G Polkinghorne, Kathryn Glass, Martyn D Kirk
Microbial Drug Resistance | MARY ANN LIEBERT, INC | Published : 2020
The study investigates the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli in gastroenteritis patients in the eight most populous regions in Australia and compares the prevalence of antimicrobial resistance in Europe and North America. A total of 164 Campylobacter isolates were collected from patients with campylobacteriosis and tested for susceptibility to six antimicrobials using ETEST® strips and compared with reports from Europe and the United States. Genomes were sequenced on Illumina NextSeq to identify genetic determinants of resistance. Phenotypically, 1.8%, 14.0%, 14.6%, and 20.1% of isolates were resistant to erythromycin (ERY), ampicillin, tet..View full abstract
Awarded by National Health and Medical Research Council
Awarded by National Health & Medical Research Council
This work was funded by a National Health and Medical Research Council grant (NHMRC GNT1116294), Agri-Futures, Australian Government Department of Health, Food Standards Australia New Zealand, New South Wales Food Authority and Queensland Health. The National Health & Medical Research Council provided research fellowship funding for M.D. K. (APP1145997).